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Introduction
We have previously shown that von Willebrand Factor (vWF)' is present in vascular subendothelium (1) , and have also found that the deposition ofvWF requires the presence ofendothelial cells (2) . vWF mediates the adhesion of platelets to exposed vascular subendothelium (3, 4) and supports subsequent thrombus formation (5) . Although vWF is generally thought of as a plasma glycoprotein, platelet adhesion to subendothelium is, to a significant extent, dependent upon the pool of vWF which has been incorporated into the subendothelial matrix (6) (7) (8) .
It is unclear as to how vWF is bound to the subendothelium. Although vWF is known to bind to fibrillar collagens types I and III (9) (10) (11) (12) , there are several reasons to doubt their involvement in vWFbindingto subendothelium. Firstly, vascular subendothelium lacks significant quantities ofthese types of collagen (13) (14) (15) . Also, Wagner et al. (16) concluded that the subendothelial binding site is not fibrillar collagen, because they found that collagenase digestion oftissue culture-derived subendothelial matrix did not remove vWF. Also, subendothe-1. Abbreviation used in this paper: vWF, von Willebrand factor. lial matrix ofcultured endothelial cells treated with a-l-a-l-dipyridyl, an inhibitor of collagen synthesis, retained the capacity to bind vWF (16) . Finally, monoclonal antibodies directed against vWF have been raised which specifically interfere with vWF-dependent platelet adhesion to subendothelial matrix but not to fibrillar collagen (17) , along with antibodies which interfere with vWF-dependent platelet adhesion to the fibrillar collagens but not to subendothelium. Thus, the subendothelial binding site(s) for vWF appear(s) to be material(s) other than the fibrillar collagens.
The aim of this study was, therefore, to investigate how vWF is bound to vascular subendothelium. Studies were initiated to examine whether purified basement membrane components bind vWF. When these studies failed to detect any binding activity, we also determined whether vWF binding proteins could be identified in extracts of vascular subendothelium. One vWF binding protein was isolated and was found to be type VI collagen.
Methods
A. Screening ofbasement membrane components Basement membrane components, including purified laminin, types IV and V collagens and an unfractionated basement membrane extract (18) , and specific polyclonal antibodies directed against laminin and types IV and V collagen were kindly provided by Dr. Hynda Kleinman and Dr. George Martin of the National Institute of Dental Research. Fibrillar collagens I and III were purchased from Sigma Chemical Co. (St. Louis, MO) and were used as positive controls to check the adequacy of the screening methods.
Protein "dot-binding" assays were performed as described (19) , with the following modifications. Nitrocellulose sheets (Schleicher & Schuell, Keene, NH) were demarcated by template into 1.0-cm squares. Varying amounts of up to 20 ,ug of each material, in a total volume of up to 20 z1, were applied to the center of each square. The sheets were then blocked with three 10-min incubations in a solution containing 0.25% BSA, 0.02% SDS, 0.1% Triton X-100, and 10 mM Tris in PBS pH 7.5 at room temperature.
Binding of laminin and types IV and V collagen to the nitrocellulose sheets was demonstrated by incubating the sheets containing each protein with its specific antibody (1/500 dilution in blocking buffer) overnight at room temperature. After three washes in the blocking buffer, the sheets were incubated with a 1/2,000 dilution ofperoxidaseconjugated goat anti-rabbit immunoglobulins (Organon Teknika; Cappel Laboratories, Cochraneville, PA), followed by three additional 10-min washes in distilled water and were then incubated with a solution containing 0.5 mg/ml chloronaphthol (Bio-Rad Laboratories, Richmond, CA), 0.01% hydrogen peroxide and 8.3 mM sodium citrate.
The sheets were then assayed for vWF binding activity in the following two ways: by incubation with vWF followed by probing with antibody against vWF, and by incubation with radiolabeled vWF followed by autoradiography.
The first approach was as follows: After blocking, the sheets were blocking buffer, incubated overnight in a 1/1,000 dilution of rabbit polyclonal anti-vWF (Calbiochem-Behring Corp., San Diego, CA), washed three times in blocking buffer, and incubated for 2 h at room temperature with a 1/2,000 dilution of peroxidase-conjugated goat anti-rabbit immunoglobulins. After washing in distilled water, the sheets were incubated with chloronaphthol and hydrogen peroxide solution as described above. The second approach was as performed as follows: After incubation with the above blocking buffer, the sheets were incubated overnight with -4 4Ci of '25I-vWF (see Methods, section D) in blocking buffer.
The sheets were then washed five times with blocking buffer containing 5% Tween-20, and subjected to autoradiography. Both of these methods detected the binding of vWF to types I and III collagen.
B. Extraction ofsubendothelium
Umbilical cords were collected immediately after delivery and the veins were flushed free ofblood with isoosmotic PBS, pH 7.4, containing the following protease inhibitors to optimize protein integrity: 10 mM n-ethyl maleimide, 5 mM phenyl-methyl-sulfonyl-fluoride, 0.1 M epsilon-aminocaproic acid, 50 mM sodium ethylene-diamine-tetraacetic acid, and 5 mM benzamidine. The veins were then mechanically deendothelialized using a modification ofthe Baumgartner method as previously described (1), and rinsed again with the above buffer. The lumens of the veins were incubated with 2% SDS, 8 M urea in 0.01 M Tris containing the above protease inhibitors (pH 8.0) for 90 min at 370C. Typically, 5 5 ml offluid was harvested from a 15-cm length of umbilical vein, yielding a protein concentration (20) of 2-5 mg/ml. Subsequent to our initial identification ofa 150-kD vWF-binding protein in these extracts as a component of type VI collagen (see below), the procedure was improved by the addition of0.02 M dithioerythritol (DTE) to the incubating solution. The extracts were initially screened for vWF binding activity by nitrocellulose dot-binding utilizing radioiodinated vWF as the probe as described above in section A. To assess the effects of the extraction process upon the internal elastic lamina, 0.5-1-cm cross-slices of umbilical vein were obtained before and after extraction, frozen in methylbutane containing dry ice, and embedded in O.C.T. (Miles Laboratories, Inc., Napierville, IL). Frozen cross-sections, measuring 2-4 mm were cut and mounted on glass slides, after which they were stained with Jenner-Giemsa and viewed.
C. Polyacrylamide gel electrophoresis and radioligand binding studies
The proteins in the extracts were resolved by electrophoresis through discontinuous PAGE (21, 22) . The gels consisted of4% (wt/vol) stacking gels over 5-15% linear gradient gel. Prestained molecular weight markers (BRL Laboratories, Gaithersburg, MD) ranging between 14,000 and 200,000 were used. After electrophoresis, the gels were equilibrated in 20 mM sodium phosphate buffer, pH 8.0, and were electrophoretically transferred at 2 A for 2 h at 4°C onto nitrocellulose sheets using an E-C electroblot chamber with an E-C 420 power supply (E-C Apparatus, St. Petersburg, FL) (23, 24) .
The nitrocellulose sheets were incubated with three changes of the same blocking buffer described above for the dot-blotted proteins for a total of 30 min. The blots were then incubated overnight with -4 ,uCi of '25I-vWF in the blocking buffer with or without a 20-fold excess of unlabeled vWF. The sheets were then washed with five changes of blocking buffer containing 0.5% Tween-20, dried, and autoradiographed using Kodak XAR-2 film in Kodak cassettes with Lanex enhancement screens and kept at -80°C until they were developed. D. Radiolabeling ofvWF vWF was prepared from fresh frozen plasma and cryoprecipitate as described (1), and was labeled with 125I by Iodogen (Pierce Chemical Co., Inc., Rockford, IL) as described (25) . Labeled (20) . The extent ofpurity ofthe eluates was evaluated by silver staining (27) (27) .
Radioimmunoligand Western blot studies. For radioimmunoligand blots, the nitrocellulose sheets were blocked with 2% nonfat dry milk in PBS, pH 7.5. They were incubated overnight with specific rabbit antisera against collagens types I, III, and VI. The antitypes I and III were kindly provided by Dr. Hynda Kleinman and Dr. George Martin ofthe National Institutes of Dental Research, and the antitype VI was provided by Dr. Rupert Timpl ofthe Max Planck Institute. The blots were then washed with three changes of blocking buffer at 10 min each, followed by three changes of PBS, and then were incubated with 2.5
UCi of 1251-protein A (Amersham Corp., Arlington Heights, IL) for 1 h in PBS without the nonfat dry milk, following which they were again washed in PBS and autoradiographed as described above.
Amino acid analysis. Lyophilized specimens were hydrolyzed for 24 h in constant boiling HO at 1070 under vacuum. Amino acid residues were derivatized with 9-fluorenylmethylchloroformate and were were then applied onto strips of nitrocellulose paper to form dot-blots. After this, the strips were treated as described above for the vWF binding protein.
Results
Our screening studies of all the initial candidate materials, including laminin, types IV and V collagen, and an unfractionated basement membrane extract failed to demonstrate any binding to vWF using both screening methods (Table I) . Be subendothelial extracts demonstrated vWF binding activity (Table I) , we undertook the subsequent experiments to identify which components of the subendothelium are responsible for the binding activity. The histology of the deendothelialized umbilical vein was observed before and after extraction of subendothelium (Fig.  1) . The extraction procedure did not result in disruption ofthe internal elastic lamina. Protein bands were resolved from the extract by gradient polyacrylamide gel electrophoresis (Fig. 1) . When the proteins were electroblotted onto nitrocellulose, incubated with '25I-vWF and autoradiographed, three major protein bands with molecular weights of 200,000, 150,000, and 80,000 were observed. The appearance of the bands was blocked by coincubation of the 123I-vWF with an excess of unlabeled vWF (Fig. 2) .
By means ofelectroelution, protein showing single bands at the 150 kD position, as assessed by silver staining of polyacrylamide gels, was obtained (Fig. 3) . The 1 50-kD protein retained the capacity to bind vWF specifically (Fig. 4, Table II ). Binding could be blocked by a 20-fold excess of unlabeled vWF. The protein had an isoelectric point of 6.0±0.2 (Fig. 5) .
Western blot studies utilizing specific antisera against collagens showed reactivity between the 150-kD protein and antitype VI collagen antibodies, but not with antibodies against types I or III collagens (Fig. 6) . Subsequent Western blot studies utilizing the whole vessel extract, also demonstrated identification ofthe 150-kD band by the antitype VI collagen antibodies, along with higher molecular weight bands (Fig. 7) .
Amino acid analysis (Table III) showed the 1 50-kD material to be a protein containing significant quantities of proline (71 residues/1,000 residues) and hydroxyproline (10 residues/ 1,000 residues). Densitometric analysis of autoradiograms of nitrocellulose dot blots, to which varying quantities of the isolated 150 kD were applied, followed by incubation with '25I-vWF. The arbitrary densitometric units represent the calculated area under each curve.
antibodies against type VI collagen, but not by antibodies against types I and III collagen. Also, its amino acid composition demonstrates a hydroxyproline-containing collagenlike protein which is similar to the compositions which have thus far been reported for type VI collagen (30) (31) (32) (33) . Also, unlike the fibrillar collagens which have basic pl's, the 1 50-kD vWF-binding protein had a pl of -6.0, similar to that previously reported for the 1 50-kD subunit of type VI collagen (34) . It is of interest that whereas type VI collagen has, with a different purification scheme and in different tissues been extracted in a disulfide bonded form (35), our initial extraction method, without reduction, identified the presence of free chains. There was, however, increased yield in the amount of 1 50-kD protein obtained after incubation with 0.02 M DTE. The presence of free chains has been previously described in porcine fibroblasts (34) , human WI-38 fibroblasts (36) , and in cutis laxa fibroblasts (37) but has not been observed in vascular subendothelium.
With respect to previous work on the vascular binding of vWF, our finding oftype VI collagen in the subendothelium is consistent with the studies of Fauvel et al. who had concluded that microfibrils constitute the blood vessel binding site for vWF (38), because it is now known that type VI collagen is a major component ofthe microfibrils. They showed that microfibrils extracted from bovine aorta using 6 31.0 Densitometric analysis of autoradiograms of nitrocellulose dot blots, to which varying quantities of the purified type VI collagen were applied, followed by incubation with 12I-vWF. The arbitrary densitometric units represent the calculated area under each curve.
observed to have a dumbell-like structure in which the central fibrillar domain is attached at each end to large globular domains (29, 43). Because the domains on vWF which are involved in binding to types I and III collagen have been identified (44) (45) (46) (47) (48) , and the structure oftype VI collagen is known, it would be interesting to learn whether there is specificity in the interaction ofany ofthe vWF domains with the various domains oftype VI collagen. Specifically, are the portions ofvWF which bind to type VI collagen the same as those responsible for binding to fibrillar collagens? And, is the fibrillar portion of the type VI molecule the region which is recognized by vWF, or do the globular portions of the molecule play a role in this binding? Interestingly, in preliminary studies, we have been unable to inhibit the binding of vWF to type VI collagen with specific antitype VI antibodies. Because these antibodies are extensively cross-absorbed with fibrillar collagens to remove cross-reactive species, it is intriguing to speculate that the binding site(s) for vWF is present on shared domain(s).
It has recently been reported that the amino acid sequence of the globular domain of type VI collagen shows striking homology to the collagen binding motifs of vWF (49) (50) (51) , and also has a region which bears homology to platelet glycoprotein lb (52) . Thus, a portion of the type VI collagen protein also shares vWFs collagen binding structure, and a portion shares homology to a glycoprotein which serves as the major platelet binding site for vWF. However, the functional significance of these homologies and the questions of whether vWF itself binds to type VI collagen via vWFs previously described binding domains for fibrillar collagens, or via a different mechanism, or a combination of mechanisms, still remain to be determined.
We have not yet identified the 80-kD band which binds vWF and suspect that this may be a partially proteolyzed chain of type VI collagen.
In conclusion, this study is the first identification ofa vWFbinding protein in subendothelium. These studies implicate type VI collagen in the process ofvWF binding to subendothelium and, therefore, to the process ofplatelet adhesion. Studies are in progress in our laboratory to further characterize the binding of vWF to type VI collagen.
